Does a clinical scientist led cardio-oncology clinic improve surveillance for cardio-toxicity for patients receiving trastuzumab compared to oncology services alone?
Event:
Heart Failure 2019
Topic:
Cardio-Oncology
Session:
Cardiovascular Disease in Special Populations
